Drug-induced hyperphagia: What can we learn from psychiatric medications?

被引:16
作者
Jensen, Gordon L. [1 ]
机构
[1] Vanderbilt Ctr Human Nutr, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
psychiatric; medications; hyperphagia; apetite; weight gain; obesity;
D O I
10.1177/0148607108321708
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This brief review examines hyperphagia and associated weight gain as undesirable side effects of psychiatric medications exploring the scope oil the problem, proposed mechanisms, and potential interventions. Mechanisms of action appear to include durg-mediated effects on hypothalamic appetite pathways that have been implicated in other etiologies of obesity There is great individual variation in response to these medications as well as variation in file degree of weight gain Within drug classes. Gene polymorphisms may be a key factor in determining individual variations in response. Better understanding of the underlying mechanisms can guide useful interventions. Medication selection and dosing appear to be important strategies to minimize adverse weight gain.
引用
收藏
页码:578 / 581
页数:4
相关论文
共 56 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial [J].
Anderson, JW ;
Greenway, FL ;
Fujioka, K ;
Gadde, KM ;
McKenney, J ;
O'Neil, PM .
OBESITY RESEARCH, 2002, 10 (07) :633-641
[3]   Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol [J].
Atmaca, M ;
Kuloglu, M ;
Tezcan, E ;
Gecici, O ;
Ustundag, B .
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) :99-100
[4]   LITHIUM AND BODY-WEIGHT GAIN [J].
BAPTISTA, T ;
TENEUD, L ;
CONTRERAS, Q ;
ALASTRE, T ;
BURGUERA, JL ;
DEBURGUERA, M ;
DEBAPTISTA, E ;
WEIS, S ;
HERNANDEZ, L .
PHARMACOPSYCHIATRY, 1995, 28 (02) :35-44
[5]   No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment [J].
Barak, Y .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (02) :117-119
[6]   Mirtazapine compared with paroxetine in major depression [J].
Benkert, O ;
Szegedi, A ;
Kohnen, R .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) :656-663
[7]  
BERENSON A, 2007, NY TIMES 0105
[8]   Topiramate and weight loss in patients with neurodevelopmental disabilities [J].
Brown, RO ;
Orr, CD ;
Hanna, DL ;
Williams, JE ;
Dickerson, RN .
PHARMACOTHERAPY, 2002, 22 (07) :831-835
[9]   Do obese depressed patients respond to topiramate? a retrospective chart review [J].
Carpenter, LL ;
Leon, Z ;
Yasmin, S ;
Price, LH .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 69 (1-3) :251-255
[10]   Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: An open-label, nonrandomized chart review [J].
Chengappa, KNR ;
Chalasani, L ;
Brar, JS ;
Parepally, H ;
Houck, P ;
Levine, J .
CLINICAL THERAPEUTICS, 2002, 24 (10) :1576-1584